Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for RGA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1995. Start Trial.
Date Value
June 30, 2026 1.773B
March 31, 2026 1.666B
December 31, 2025 1.985B
September 30, 2025 4.206B
June 30, 2025 540.00M
March 31, 2025 2.067B
December 31, 2024 797.00M
September 30, 2024 639.00M
June 30, 2024 1.22B
March 31, 2024 1.005B
December 31, 2023 349.00M
September 30, 2023 -639.00M
June 30, 2023 -129.00M
March 31, 2023 497.00M
December 31, 2022 63.00M
September 30, 2022 1.777B
June 30, 2022 832.00M
March 31, 2022 1.764B
December 31, 2021 697.00M
September 30, 2021 -377.00M
June 30, 2021 -157.00M
March 31, 2021 -143.00M
December 31, 2020 20.00M
September 30, 2020 -99.00M
June 30, 2020 1.026B
Date Value
March 31, 2020 307.00M
December 31, 2019 -101.41M
September 30, 2019 -204.70M
June 30, 2019 494.93M
March 31, 2019 -309.82M
December 31, 2018 350.22M
September 30, 2018 -303.13M
June 30, 2018 -253.66M
March 31, 2018 -115.40M
December 31, 2017 -236.63M
September 30, 2017 -210.19M
June 30, 2017 470.03M
March 31, 2017 -347.84M
December 31, 2016 -1.127M
September 30, 2016 103.50M
June 30, 2016 655.63M
March 31, 2016 297.39M
December 31, 2015 -166.49M
September 30, 2015 -125.32M
June 30, 2015 -76.58M
March 31, 2015 -339.90M
December 31, 2014 254.23M
September 30, 2014 -133.34M
June 30, 2014 -175.68M
March 31, 2014 -200.77M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Primerica, Inc. -172.84M
Oscar Health, Inc. 13.30M
Unum Group 2.50M
Novus Acquisition & Development Corp. 0.00
Bowhead Specialty Holdings, Inc. 0.00